CT:LABS Medipharm Labs Corp

MediPharm Labs Corp., together with its subsidiaries, produces and sells pharma-grade cannabis oil and concentrates for derivative products in Canada and Australia. It also provides cannabis contract processing services to licensed producers and growers; and tolling services to Canadian licensed cultivators of cannabis for selling cannabis oil, formulations, and derivatives under their own brand. In addition, the company supplies purified cannabis concentrate raw materials and product formulations for ready-to-sell advanced cannabis products. Further, it engages in the real estate business. The company was founded in 2015 and is headquartered in Barrie, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol MEDIF.

0.19 CAD
As of 12/06/2021


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  Canada
Country of incorporation:  Canada
IPO date:  07/29/2019
Stock exchange:    Toronto Stock Exchange
Exchange country:   Canada
Market cap:   51,546,867 CAD
Current dividend yield:   0.00%
CUSIP:    
ISIN:        CA58504D1006
Sedol:      BG87WT7

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy